The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR
Open accessAbstract
Immunoglobulin G (IgG) Fc receptors play a critical role in linking IgG antibody-mediated immune responses with cellular effector functions. A high resolution map of the binding site on human IgG1 for human Fc gamma RI, Fc gamma RIIA, Fc gamma RIIB, Fc gamma RIIIA, and FcRn receptors has been determined. A common set of IgG1 residues is involved in binding to all Fc gamma R; Fc gamma RII and Fc gamma RIII also utilize residues outside this common set. In addition to residues which, when altered, abrogated binding to one or more of the receptors, several residues were found that improved binding only to specific receptors or simultaneously improved binding to one type of receptor and reduced binding to another type. Select IgG1 variants with improved binding to Fc gamma RIIIA exhibited up to 100% enhancement in antibody-dependent cell cytotoxicity using human effector cells; these variants included changes at residues not found at the binding interface in the IgG/Fc gamma RIIIA co-crystal structure (Sondermann, P., Huber, R., Oosthuizen, V., and Jacob, U. (2000) Nature 406, 267-273). These engineered antibodies may have important implications for improving antibody therapeutic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid and efficient site-specific mutagenesis without phenotypic selection.
Kunkel, T. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.2.488 · Cited by 7,206
Sequences of proteins of immunological interest
(1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90805-4 · Cited by 3,363
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
Clynes, R. A., Towers, T. L., Presta, L. G., & Ravetch, J. V. (2000) · Nature Medicine · doi:10.1038/74704 · Cited by 2,768
Establishment and characterization of a human acute monocytic leukemia cell line (THP‐1)
Tsuchiya, S., Yamabe, M., Yamaguchi, Y., Kobayashi, Y., Konno, T., & Tada, K. (1980) · International Journal of Cancer · doi:10.1002/ijc.2910260208 · Cited by 2,254
Humanization of an anti-p185HER2 antibody for human cancer therapy.
Carter, P., Presta, L., Gorman, C. M., Ridgway, J. B., Henner, D., Wong, W. L., Rowland, A. M., Kotts, C., Carver, M. E., & Shepard, H. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4285 · Cited by 1,918
Self-citationPresta, L. G., Chen, H., O'Connor, S. J., Chisholm, V., Meng, Y. G., KRUMMEN, L. A., Winkler, M., & Ferrara, N. (1997) · PubMed · Cited by 1,608
Self-citationDeisenhofer, J. (1981) · PubMed · Cited by 1,422
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
Daëron, M. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.203 · Cited by 1,227
The I.M.A.G.E. Consortium: An Integrated Molecular Analysis of Genomes and Their Expression
Lennon, G., Auffray, C., Polymeropoulos, M., & Soares, M. B. (1996) · Genomics · doi:10.1006/geno.1996.0177 · Cited by 1,123
Koene, H. R., Kleijer, M., Algra, J., Roos, D., E.G.Kr. von dem Borne, A., & de Haas, M. (1997) · Blood · doi:10.1182/blood.v90.3.1109 · Cited by 794
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
Hudziak, R. M., Lewis, G. D., Winget, M., Fendly, B. M., Shepard, H. M., & Ullrich, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.3.1165 · Cited by 749
The 3.2-Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex
Sondermann, P., Huber, R., Oosthuizen, V., & Jacob, U. (2000) · Nature · doi:10.1038/35018508 · Cited by 719
Wu, J., Edberg, J. C., Redecha, P. B., Bansal, V, Guyre, P. M., Coleman, K., Salmon, J. E., & Kimberly, R. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119616 · Cited by 711
Designing CD4 immunoadhesins for AIDS therapy
Capon, D. J., Chamow, S. M., Mordenti, J., Marsters, S. A., Gregory, T., Mitsuya, H., Byrn, R. A., Lucas, C., Wurm, F. M., Groopman, J. E., et al. (1989) · Nature · doi:10.1038/337525a0 · Cited by 615
Humanization of an antibody directed against IgE.
Presta, L. G., Lahr, S. J., Shields, R. L., Porter, J. P., Gorman, C. M., Fendly, B. M., & Jardieu, P. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2623 · Cited by 474
Self-citationRefined Structure of an Intact IgG2a Monoclonal Antibody,
Harris, L. J., Larson, S. B., Hasel, K. W., & McPherson, A. (1997) · Biochemistry · doi:10.1021/bi962514+ · Cited by 451
Crystallographic structure of an intact IgG1 monoclonal antibody 1 1Edited by I. A. Wilson
Harris, L. J., Skaletsky, E., & McPherson, A. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1508 · Cited by 440
Crystal structure of the complex of rat neonatal Fc receptor with Fc
Burmeister, W. P., Huber, A. H., & Bjorkman, P. J. (1994) · Nature · doi:10.1038/372379a0 · Cited by 431
Mapping of the C1q Binding Site on Rituxan, a Chimeric Antibody with a Human IgG1 Fc
Idusogie, E. E., Presta, L. G., Gazzano-Santoro, H., Totpal, K., Wong, P. Y., Ultsch, M., Meng, Y. G., & Mulkerrin, M. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4178 · Cited by 424
Self-citationGessner, J. E., Heiken, H., Tamm, A., & Schmidt, R. E. (1998) · Annals of Hematology · doi:10.1007/s002770050396 · Cited by 404
Crystal structure of the complex of rat neonatal Fc receptor with Fc
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90005-5 · Cited by 381
Nilsson, K., Bennich, H., Johansson, S. G. O., & Pontén, J. (1970) · PubMed Central · Cited by 368
Fc receptors are required in passive and active immunity to melanoma
Clynes, R., Takechi, Y., Moroi, Y., Houghton, A., & Ravetch, J. V. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.652 · Cited by 321
Raghavan, M., Bonagura, V. R., Morrison, S. L., & Bjorkman, P. J. (1995) · Biochemistry · doi:10.1021/bi00045a005 · Cited by 317
Fc RECEPTORS AND THEIR INTERACTIONS WITH IMMUNOGLOBULINS
Raghavan, M., & Bjorkman, P. J. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.181 · Cited by 314
Localization of the binding site for the human high-affinity Fc receptor on IgG
Duncan, A. R., Woof, J. M., Partridge, L. J., Burton, D. R., & Winter, G. (1988) · Nature · doi:10.1038/332563a0 · Cited by 288
Papac, D. I., Wong, A., & Jones, A. J. S. (1996) · Analytical Chemistry · doi:10.1021/ac960324z · Cited by 277
Eaton, D. L., Wood, W. I., Eaton, D., Hass, P. E., Hollingshead, P., Wion, K., Mather, J., Lawn, R. M., Vehar, G. A., & Gorman, C. (1986) · Biochemistry · doi:10.1021/bi00374a001 · Cited by 267
Canfield, S. M., & Morrison, S. L. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1483 · Cited by 266
Anderson, D. R., Grillo-López, A., Varns, C., Chambers, K. S., & Hanna, N. (1997) · Biochemical Society Transactions · doi:10.1042/bst0250705 · Cited by 248
Increasing the serum persistence of an IgG fragment by random mutagenesis
Ghetie, V., Popov, S., Borvak, J., Radu, C., Matesoi, D., Medesan, C., Ober, R. J., & Ward, E. S. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-637 · Cited by 241
Lund, J., Takahashi, N., Pound, J. D., Goodall, M., & Jefferis, R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4963 · Cited by 216
FcRn: the MHC class I-related receptor that is more than an IgG transporter
Ghetie, V., & Ward, E. S. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01172-9 · Cited by 216
Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa.
Hogarth, P. M., Maxwell, K. F., Powell, M. S., Hulett, M. D., Bartoň, P., McKenzie, I. F. C., & Garrett, T. (1999) · Nature Structural Biology · doi:10.1038/8241 · Cited by 195
Recombinant human IgG molecules lacking Fcγ receptor I binding and monocyte triggering activities
Armour, K. L., Clark, M. R., Hadley, A. G., & Williamson, L. M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199908)29:08<2613::aid-immu2613>3.0.co;2-j · Cited by 192
Lehrnbecher, T., Foster, C. B., Zhu, S., Leitman, S. F., Goldin, L. R., Huppi, K., & Chanock, S. J. (1999) · Blood · doi:10.1182/blood.v94.12.4220 · Cited by 183
Lifely, M. R., Hale, C., Boyce, S., Keen, M. J., & Phillips, J. (1995) · Glycobiology · doi:10.1093/glycob/5.8.813 · Cited by 178
Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1
Medesan, C., Matesoi, D., Radu, C., Ghetie, V, & Ward, E. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.5.2211 · Cited by 175
Functional analysis of human Fc gamma RII (CD32) isoforms expressed in B lymphocytes.
van den Herik–Oudijk, I. E., WESTERDAAL, N. A. C., Henriquez, N. V., Capel, P. J., & van de Winkel, J. G. J. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.574 · Cited by 162
Tax, W. J. M., Hermes, F. F. M., Willems, R., Capel, P. J., & Koene, R. A. P. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.3.1185 · Cited by 156
Wines, B. D., Powell, M. S., Parren, P. W. H. I., Barnes, N. C., & Hogarth, P. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5313 · Cited by 152
Papac, D. I. (1998) · Glycobiology · doi:10.1093/glycob/8.5.445 · Cited by 151
Liu, J., Lester, P. M., Builder, S. E., & Shire, S. J. (1995) · Biochemistry · doi:10.1021/bi00033a020 · Cited by 147
Kim, J., Tsen, M. F., Ghetie, V. F., & Ward, E. S. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241025 · Cited by 144
Chappel, M. S., Isenman, D. E., Everett, M., Xu, Y. Y., Dorrington, K. J., & Klein, M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9036 · Cited by 131
Three-dimensional structure of a human immunoglobulin with a hinge deletion.
Guddat, L. W., Herron, J. N., & Edmundson, A. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4271 · Cited by 125
Sondermann, P., Huber, R., & Jacob, U. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1095 · Cited by 123
Localisation of the monocyte-binding region on human immunoglobulin G
Woof, J. M., Partridge, L. J., Jefferis, R., & Burton, D. R. (1986) · Molecular Immunology · doi:10.1016/0161-5890(86)90059-3 · Cited by 120
Kim, J., Tsen, M. F., Ghetie, V. F., & Ward, E. S. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240308 · Cited by 118
Molecular basis for a polymorphism involving Fc receptor II on human monocytes.
Clark, M. R., Clarkson, S., Ory, P. A., Stollman, N., & Goldstein, I. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.5.1731 · Cited by 112
Binding characteristics of dimeric IgG subclass complexes to human neutrophils.
Huizinga, T. W. J., Kerst, M., Nuyens, J. H., Vlug, A., Borne, A. E. G. K. V. D., Roos, D., & Tetteroo, P. A. T. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.7.2359 · Cited by 109
Sármay, G., Lund, J., Rozsnyay, Z., Gergely, J., & Jefferis, R. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90200-h · Cited by 109
Meng, Y. G., Liang, J., Wong, W. L., & Chisholm, V. (2000) · Gene · doi:10.1016/s0378-1119(99)00524-7 · Cited by 99
Self-citationLucas, B. K., Giere, L., DeMarco, R., Shen, A., Chisholm, V., & Crowley, C. W. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.9.1774 · Cited by 98
A novel role for the Fc receptor gamma subunit: enhancement of Fc gamma R ligand affinity.
Miller, K. L., Duchemin, A., & Anderson, C. L. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2227 · Cited by 79
Oligosaccharide‐protein interactions in IgG can modulate recognition by Fcγ receptors
Lund, J., Takahashi, N., Pound, J. D., Goodall, M. D., Nakagawa, H., & Jefferis, R. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.1.7821750 · Cited by 72
Kim, J., Tsen, M. F., Ghetie, V. F., & Ward, E. S. (1994) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1994.tb03488.x · Cited by 70
Variant genotypes of FcγRIIIA influence the development of Kaposi's sarcoma in HIV-infected men
nbecher, T. L., Foster, C. B., Zhu, S., Venzon, D. J., Steinberg, S. M., Wyvill, K. M., Metcalf, J. A., Cohen, S. S., Kovacs, J. A., Yarchoan, R., et al. (2000) · Blood · doi:10.1182/blood.v95.7.2386 · Cited by 67
Molecular definition of interaction sites on human IgG for Fc receptors (huFcγR)
Jefferis, R., Lund, J., & Pound, J. D. (1990) · Molecular Immunology · doi:10.1016/0161-5890(90)90027-w · Cited by 61
Tamm, A., Kister, A. E., Nolte, K., Gessner, J. E., & Schmidt, R. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3659 · Cited by 60
Humanized Antibodies as Potential Therapeutic Drugs
Vaswani, S. K., & Hamilton, R. G. (1998) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62794-9 · Cited by 59
Multiple binding sites on the CH2 domain of IgG for mouse FcγR11
Lund, J., Pound, J. D., Jones, P., Duncan, A., Bentley, T., Goodall, M. D., Levine, B. A., Jefferis, R., & Winte, G. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90156-r · Cited by 59
Novel Fc gamma receptor I family gene products in human mononuclear cells.
Porges, A. J., Redecha, P. B., Doebele, R. C., Pan, L. C., Salmon, J. E., & Kimberly, R. P. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116094 · Cited by 45
The Immunoglobulin Receptors and their Physiological and Pathological Roles in Immunity
van de Winkel, J. G. J., & Hogarth, P. M. (1998) · Springer eBooks · doi:10.1007/978-94-011-5018-7 · Cited by 40
Antibodies come back from the brink
Holliger, P., & Hoogenboom, H. R. (1998) · Nature Biotechnology · doi:10.1038/3460 · Cited by 38
Molecular recognition of antibody (IgG) by cellular Fc receptor (FcRI)
Burton, D. R., Jefferis, R., Partridge, L. J., & Woof, J. M. (1988) · Molecular Immunology · doi:10.1016/0161-5890(88)90153-8 · Cited by 36
Haagen, I.-A., Geerars, A., Clark, M., & van de Winkel, J. G. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.4.1852 · Cited by 30
Romas (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200004)43:4
Cited by
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947
IgG Subclasses and Allotypes: From Structure to Effector Functions
Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Shields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Self-citation
Metadata
- Authors
- Shields, R. L., Namenuk, A. K., Hong, K., Meng, Y. G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., Fox, J. A., & Presta, L. G.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-03
- Volume
- 276
- Issue
- 9
- Pages
- 6591-6604
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1529809181
- Cited by
- 1,161
- References
- 70
- FWCI
- 20.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.